Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
According to recommendations from nutrition institutes and the World Health Organization (WHO), the daily Recommended Dietary Allowance (RDA) is as follows: Infants 06 months: 0.4 mcg Infants 712 months: 0.5 mcg Children 13 years: 0.9 mcg Children 48 years: 1.2 mcg Children 913 years: 1.8 mcg Teenagers 14+ years and adults: 2.4 mcg Pregnant women: 2.6 mcg Breastfeeding women: 2.8 mcg Receiving adequate daily Vitamin B12 helps reduce the risk of anemia, fatigue, and neurological problems, while supporting optimal metabolic and overall bodily function
Contraindications: allergy to ingredients, certain liver/kidney conditions, or B12 sensitivity.
Administer Immediately: The two peptides are now mixed in the syringe, but only for a few moments
useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established
